Amundi’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $637K | Buy |
113,195
+76,330
| +207% | +$430K | ﹤0.01% | 1315 |
|
|
2025
Q1 | $310K | Sell |
36,865
-7,113
| -16% | -$59.8K | ﹤0.01% | 1592 |
|
|
2024
Q4 | $650K | Buy |
43,978
+27,989
| +175% | +$414K | ﹤0.01% | 1505 |
|
|
2024
Q3 | $415K | Buy |
15,989
+1,892
| +13% | +$49.1K | ﹤0.01% | 1476 |
|
|
2024
Q2 | $352K | Sell |
14,097
-6,265
| -31% | -$156K | ﹤0.01% | 1424 |
|
|
2024
Q1 | $377K | Buy |
20,362
+3,934
| +24% | +$72.8K | ﹤0.01% | 1481 |
|
|
2023
Q4 | $297K | Buy |
16,428
+5,985
| +57% | +$108K | ﹤0.01% | 1536 |
|
|
2023
Q3 | $152K | Sell |
10,443
-15
| -0.1% | -$218 | ﹤0.01% | 1661 |
|
|
2023
Q2 | $243K | Sell |
10,458
-940
| -8% | -$21.8K | ﹤0.01% | 1554 |
|
|
2023
Q1 | $265K | Buy |
+11,398
| New | +$265K | ﹤0.01% | 1495 |
|
|
2021
Q3 | – | Sell |
-136,000
| Closed | -$4.16M | – | 1590 |
|
|
2021
Q2 | $4.16M | Buy |
+136,000
| New | +$4.16M | ﹤0.01% | 1042 |
|